"Központjainkban mintegy 90 féle alvászavart diagnosztizálunk és kezelünk egyedülálló szakértelemmel. Budapesten, Pécsen és Szegeden várjuk mindazokat, akik szeretnének újra kipihenten ébredni."

During the past decade, SomnoCenter Budapest conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SomnoCenter Budapest" are "Insomnia Disorder" (2 trials), "Narcolepsy Type 1 (NT 1)" (1 trials), "Narcolepsy Type 1 (NT1)" (1 trials) and "Narcolepsy Type 2 (NT2)" (1 trials). Many other conditions were trialed in "SomnoCenter Budapest" in a lesser frequency.

Most popular intervention types in "SomnoCenter Budapest" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "TAK-994" (2 trials), "Daridorexant" (1 trials), "Daridorexant 10 mg" (1 trials) and "Daridorexant 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "SomnoCenter Budapest" are 4 trials for "All" genders.

Currently, there are NaN active trials in "SomnoCenter Budapest". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SomnoCenter Budapest, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SomnoCenter Budapest, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".